Oncolytics Biotech Inc.
General ticker "ONCY" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $71.7M (TTM average)
Oncolytics Biotech Inc. follows the US Stock Market performance with the rate: 41.9%.
Estimated limits based on current volatility of 3.6%: low 1.04$, high 1.12$
Factors to consider:
- Total employees count: 9 as of 2002
- Price in estimated range
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-12-31 to 2027-12-31
- 2025-12-31 to 2026-12-31 estimated range: [0.69$, 1.75$]
- 2026-12-31 to 2027-12-31 estimated range: [0.66$, 1.70$]
Financial Metrics affecting the ONCY estimates:
- Positive: with PPE of -3.3 at the end of fiscal year the price was neutral
- Negative: negative Operating income
- Negative: Operating cash flow per share per price, % of -21.99 <= 0.07
- Positive: Investing cash flow per share per price, % of -0.01 > -0.65
- Positive: Inventory ratio change, % of 0 <= 0
- Negative: Shareholder equity ratio, % of -50.11 <= 19.49
- Positive: Interest expense per share per price, % of 0 <= 0.01
Short-term ONCY quotes
Long-term ONCY plot with estimates
Financial data
| YTD | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|
| Operating Revenue | CA$0.00MM | CA$0.00MM | CA$0.00MM |
| Operating Expenses | CA$25.04MM | CA$34.98MM | CA$28.73MM |
| Operating Income | CA$-25.04MM | CA$-34.98MM | CA$-28.73MM |
| Non-Operating Income | CA$4.55MM | CA$3.40MM | CA$0.04MM |
| R&D Expense | CA$13.12MM | CA$21.65MM | CA$13.31MM |
| Income(Loss) | CA$-20.49MM | CA$-31.58MM | CA$-28.68MM |
| Taxes | CA$0.07MM | CA$0.13MM | CA$0.08MM |
| Profit(Loss)* | CA$-27.75MM | CA$-31.71MM | CA$-28.76MM |
| Stockholders Equity | CA$27.56MM | CA$5.98MM | CA$-3.80MM |
| Assets | CA$38.82MM | CA$20.19MM | CA$7.58MM |
| Operating Cash Flow | CA$-28.45MM | CA$-26.97MM | CA$-20.11MM |
| Capital expenditure | CA$0.01MM | CA$0.24MM | CA$0.01MM |
| Investing Cash Flow | CA$20.22MM | CA$-0.24MM | CA$-0.01MM |
| Financing Cash Flow | CA$31.99MM | CA$6.64MM | CA$14.12MM |
| Earnings Per Share** | CA$-0.41 | CA$-0.41 | CA$-0.30 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.